Last 12 months
Inside the activity.
6 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2024 Filed Mar 4, 2024 17:59 UTC |
HALEY JOHN JDirector
|
GrantDividend Equivalent Rights · Derivative | 58.851 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000030 · primary_doc.xml · derivative · entry 1 HALEY JOHN J · CIK 0001215018 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,470.611 Underlying: Common Stock · 58.851 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:43 UTC |
GOLINVAUX THERESA DPrincipal Accounting Officer
|
GrantDividend Equivalent Rights · Derivative | 31.272 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000029 · primary_doc.xml · derivative · entry 1 GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,751.96 Underlying: Common Stock · 31.272 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:36 UTC |
Caswell BruceCEO & President
|
GrantDividend Equivalent Rights · Derivative | 611.637 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000028 · primary_doc.xml · derivative · entry 1 Caswell Bruce · CIK 0001311296 · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,176.723 Underlying: Common Stock · 611.637 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:30 UTC |
Altman Anne K.Director
|
GrantDividend Equivalent Rights · Derivative | 10.509 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000027 · primary_doc.xml · derivative · entry 1 Altman Anne K. · CIK 0001637502 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,941.114 Underlying: Common Stock · 10.509 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:19 UTC |
RAJAN GAYATHRIDirector
|
GrantDividend Equivalent Rights · Derivative | 7.23 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000026 · primary_doc.xml · derivative · entry 1 RAJAN GAYATHRI · CIK 0001698399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,023.284 Underlying: Common Stock · 7.23 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:06 UTC |
Baylinson Ilene R.General Mgr - Health & Human
|
GrantDividend Equivalent Rights · Derivative | 115.704 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000025 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,381.53 Underlying: Common Stock · 115.704 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 16:28 UTC |
Mutryn DavidChief Financial Officer
|
GrantDividend Equivalent Rights · Derivative | 144.425 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000023 · primary_doc.xml · derivative · entry 1 Mutryn David · CIK 0001896008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,419.473 Underlying: Common Stock · 144.425 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 19:33 UTC Amendment |
RAJAN GAYATHRIDirector
|
PurchaseCommon Stock | 56.33 | $84.06 | $4,734.82 |
DisclosureSEC source: 0001032220-24-000038 · primary_doc.xml · nonDerivative · entry 1 RAJAN GAYATHRI · CIK 0001698399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,839.065 F1 · shares: Shares purchased via dividend reinvestment. Read SEC document |
| February 29, 2024 Filed Sep 10, 2024 18:53 UTC |
Warren Michael J.Director
|
PurchaseCommon Stock | 7.18 | $84.05 | $603.48 |
DisclosureSEC source: 0001032220-24-000089 · primary_doc.xml · nonDerivative · entry 1 Warren Michael J. · CIK 0001698331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,040.69 F1 · shares: Shares purchased via dividend reinvestment. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 19:40 UTC |
Mutryn DavidChief Financial Officer
|
SaleCommon Stock | 8,000 | $83.95 | $671,624.00 |
DisclosureSEC source: 0001032220-24-000016 · primary_doc.xml · nonDerivative · entry 1 Mutryn David · CIK 0001896008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,123.53 F1 · security: These sales were completed pursuant to a 10b5-1 trading plan adopted by the reporting person on November 17, 2023. F2 · price: The weighted average sales price for prices ranging from $83.20 to $84.70. The reporting person will provide full information regarding the number of shares purchased or sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 21:02 UTC |
Weipert TeresaGM - US Federal Services
|
SaleCommon Stock | 2,145 | $85.19 | $182,737.05 |
DisclosureSEC source: 0001032220-23-000120 · primary_doc.xml · nonDerivative · entry 1 Weipert Teresa · CIK 0001856024 · GM - US Federal Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,348.31 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F2 · price: Weighted average sales price for prices ranging from $85.16 to $85.29. The reporting person will provide full information regarding the number of shares purchased or sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 19:35 UTC |
Baylinson Ilene R.General Mgr - Health & Human
|
SaleCommon Stock | 10,043 | $85.57 | $859,359.42 |
DisclosureSEC source: 0001032220-23-000118 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,001.935 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. Read SEC document |
| December 04, 2023 Filed Dec 14, 2023 20:34 UTC |
Link Michelle F.Chief of Human Resources
|
SaleCommon Stock | 1,765 | $85.21 | $150,395.65 |
DisclosureSEC source: 0001032220-23-000119 · primary_doc.xml · nonDerivative · entry 1 Link Michelle F. · CIK 0001808982 · Chief of Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,981.26 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 18:38 UTC |
RUDDY RAYMOND BDirector
|
GrantDividend Equivalent Rights · Derivative | 701.889 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000105 · primary_doc.xml · derivative · entry 1 RUDDY RAYMOND B · CIK 0001054997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,036.738 Underlying: Common Stock · 701.889 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 00:55 UTC |
Caswell BruceCEO & President
|
GrantDividend Equivalent Rights · Derivative | 70.904 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000115 · primary_doc.xml · derivative · entry 2 Caswell Bruce · CIK 0001311296 · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,803.35 Underlying: Common Stock · 70.904 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F2 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F2 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 00:55 UTC |
Caswell BruceCEO & President
|
Tax withholdingCommon Stock | 49 | $83.49 | $4,091.01 |
DisclosureSEC source: 0001032220-23-000115 · primary_doc.xml · nonDerivative · entry 1 Caswell Bruce · CIK 0001311296 · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,784.052 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 00:40 UTC |
GOLINVAUX THERESA DPrincipal Accounting Officer
|
GrantDividend Equivalent Rights · Derivative | 14.61 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000114 · primary_doc.xml · derivative · entry 1 GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,080.525 Underlying: Common Stock · 14.61 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 00:33 UTC |
Link Michelle F.Chief of Human Resources
|
GrantDividend Equivalent Rights · Derivative | 18.205 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000113 · primary_doc.xml · derivative · entry 2 Link Michelle F. · CIK 0001808982 · Chief of Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,084.663 Underlying: Common Stock · 18.205 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F2 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F2 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 00:33 UTC |
Link Michelle F.Chief of Human Resources
|
Tax withholdingCommon Stock | 7 | $83.49 | $584.43 |
DisclosureSEC source: 0001032220-23-000113 · primary_doc.xml · nonDerivative · entry 1 Link Michelle F. · CIK 0001808982 · Chief of Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,746.26 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 00:13 UTC |
Mutryn DavidChief Financial Officer
|
GrantDividend Equivalent Rights · Derivative | 37.209 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000112 · primary_doc.xml · derivative · entry 1 Mutryn David · CIK 0001896008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,392.554 Underlying: Common Stock · 37.209 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 00:03 UTC |
Warren Michael J.Director
|
GrantDividend Equivalent Rights · Derivative | 32.765 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000111 · primary_doc.xml · derivative · entry 1 Warren Michael J. · CIK 0001698331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,151.137 Underlying: Common Stock · 32.765 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 23:58 UTC |
RAJAN GAYATHRIDirector
|
GrantDividend Equivalent Rights · Derivative | 7.218 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000110 · primary_doc.xml · derivative · entry 1 RAJAN GAYATHRI · CIK 0001698399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,016.054 Underlying: Common Stock · 7.218 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 23:53 UTC |
Madsen JanDirector
|
GrantDividend Equivalent Rights · Derivative | 49.916 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000109 · primary_doc.xml · derivative · entry 1 Madsen Jan · CIK 0001629769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,941.684 Underlying: Common Stock · 49.916 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 23:50 UTC |
HALEY JOHN JDirector
|
GrantDividend Equivalent Rights · Derivative | 58.76 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000108 · primary_doc.xml · derivative · entry 1 HALEY JOHN J · CIK 0001215018 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,411.76 Underlying: Common Stock · 58.76 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 23:46 UTC |
Altman Anne K.Director
|
GrantDividend Equivalent Rights · Derivative | 10.5 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000107 · primary_doc.xml · derivative · entry 1 Altman Anne K. · CIK 0001637502 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,930.605 Underlying: Common Stock · 10.5 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 23:40 UTC |
Baylinson Ilene R.General Mgr - Health & Human
|
GrantDividend Equivalent Rights · Derivative | 32.26 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000106 · primary_doc.xml · derivative · entry 2 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,010.02 Underlying: Common Stock · 32.26 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 23:40 UTC |
Baylinson Ilene R.General Mgr - Health & Human
|
SaleCommon Stock | 12 | $83.49 | $1,001.88 |
DisclosureSEC source: 0001032220-23-000106 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,717.3 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 30, 2023 Filed Jan 12, 2024 20:36 UTC |
RAJAN GAYATHRIDirector
|
PurchaseCommon Stock | 56.592 | $83.37 | $4,717.83 |
DisclosureSEC source: 0001032220-24-000004 · primary_doc.xml · nonDerivative · entry 4 RAJAN GAYATHRI · CIK 0001698399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,782.735 F1 · shares: Shares purchased via dividend reinvestment Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 15:56 UTC |
MONTONI RICHARD ADirector
|
GiftCommon Stock | 2,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000104 · primary_doc.xml · nonDerivative · entry 1 MONTONI RICHARD A · CIK 0001254635 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · In Trust Disclosed balance after: 70,000 F1 · security: Reflects the gift of common stock to a charitable donor advised fund. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:42 UTC |
Martinez John ThomasGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 7,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000103 · primary_doc.xml · derivative · entry 1 Martinez John Thomas · CIK 0001993862 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,331 Underlying: Common Stock · 7,331 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F2 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F3 · balance_after: Reporting person also holds restricted stock units with respect to an additional 3,811 shares of common stock with varying vesting schedules. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:31 UTC |
Weipert TeresaGeneral Manager - US Federal S
|
GrantRestricted Stock Units · Derivative | 7,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000102 · primary_doc.xml · derivative · entry 1 Weipert Teresa · CIK 0001856024 · General Manager - US Federal S 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,942 Underlying: Common Stock · 7,942 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F2 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F3 · balance_after: Reporting person also holds restricted stock units with respect to an additional 5,350.472 shares of common stock with varying vesting schedules. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:07 UTC |
Mutryn DavidChief Financial officer
|
GrantRestricted Stock Units · Derivative | 9,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000100 · primary_doc.xml · derivative · entry 3 Mutryn David · CIK 0001896008 · Chief Financial officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,164 Underlying: Common Stock · 9,164 shares Expires not disclosed F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 10,355.345 shares of common stock with varying vesting schedules. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:55 UTC |
Baylinson Ilene R.General Manager - Health & Hum
|
GrantRestricted Stock Units · Derivative | 7,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000099 · primary_doc.xml · derivative · entry 3 Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,331 Underlying: Common Stock · 7,331 shares Expires not disclosed F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 8,977.76 shares of common stock with varying vesting schedules. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:40 UTC |
GOLINVAUX THERESA DPrincipal Accounting Officer
|
GrantRestricted Stock Units · Derivative | 2,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000098 · primary_doc.xml · derivative · entry 3 GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,520 Underlying: Common Stock · 2,520 shares Expires not disclosed F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 4-year ratable vest that occurs on 09/30/2024, 09/30/2025, 09/30/2026, and 09/30/2027. F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 4-year ratable vest that occurs on 09/30/2024, 09/30/2025, 09/30/2026, and 09/30/2027. F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 4,065.915 shares of common stock with varying vesting schedules. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:18 UTC |
Link Michelle F.Chief Human Resource Officer
|
GrantRestricted Stock Units · Derivative | 4,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000097 · primary_doc.xml · derivative · entry 3 Link Michelle F. · CIK 0001808982 · Chief Human Resource Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,888 Underlying: Common Stock · 4,888 shares Expires not disclosed F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 5,088.458 shares of common stock with varying vesting schedules. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:19 UTC |
Caswell BruceCEO & President
|
Tax withholdingCommon Stock | 11,888 | $82.31 | $978,501.28 |
DisclosureSEC source: 0001032220-23-000101 · primary_doc.xml · nonDerivative · entry 2 Caswell Bruce · CIK 0001311296 · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,733.023 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:19 UTC |
Caswell BruceCEO & President
|
GrantCommon Stock | 24,611.023 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000101 · primary_doc.xml · nonDerivative · entry 1 Caswell Bruce · CIK 0001311296 · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,621.023 F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 10,705 performance stock units which were previously reported on a Form 4 filed on November 22, 2021. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:07 UTC |
Mutryn DavidChief Financial officer
|
Tax withholdingCommon Stock | 98 | $82.31 | $8,066.38 |
DisclosureSEC source: 0001032220-23-000100 · primary_doc.xml · nonDerivative · entry 2 Mutryn David · CIK 0001896008 · Chief Financial officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,123.53 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 22:07 UTC |
Mutryn DavidChief Financial officer
|
GrantCommon Stock | 213.766 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000100 · primary_doc.xml · nonDerivative · entry 1 Mutryn David · CIK 0001896008 · Chief Financial officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,221.53 F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 92.892 performance stock units which were previously reported on a Form 3 filed on December 1, 2021. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:55 UTC |
Baylinson Ilene R.General Manager - Health & Hum
|
Tax withholdingCommon Stock | 2,681 | $82.31 | $220,673.11 |
DisclosureSEC source: 0001032220-23-000099 · primary_doc.xml · nonDerivative · entry 2 Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,707.752 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:55 UTC |
Baylinson Ilene R.General Manager - Health & Hum
|
GrantCommon Stock | 5,349.325 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000099 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,388.752 F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 2,326.38 performance stock units which were previously reported on a Form 4 filed on November 22, 2021. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:40 UTC |
GOLINVAUX THERESA DPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 181 | $82.31 | $14,898.11 |
DisclosureSEC source: 0001032220-23-000098 · primary_doc.xml · nonDerivative · entry 2 GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,787.471 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:40 UTC |
GOLINVAUX THERESA DPrincipal Accounting Officer
|
GrantCommon Stock | 400.04 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000098 · primary_doc.xml · nonDerivative · entry 1 GOLINVAUX THERESA D · CIK 0001741289 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,968.471 F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 173.67 performance stock units which were previously reported on a Form 3 filed on December 1, 2021. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:18 UTC |
Link Michelle F.Chief Human Resource Officer
|
Tax withholdingCommon Stock | 1,448 | $82.31 | $119,184.88 |
DisclosureSEC source: 0001032220-23-000097 · primary_doc.xml · nonDerivative · entry 2 Link Michelle F. · CIK 0001808982 · Chief Human Resource Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,740.337 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:18 UTC |
Link Michelle F.Chief Human Resource Officer
|
GrantCommon Stock | 3,208.577 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000097 · primary_doc.xml · nonDerivative · entry 1 Link Michelle F. · CIK 0001808982 · Chief Human Resource Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,188.337 F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 1,395.424 performance stock units which were previously reported on a Form 4 filed on November 22, 2021. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 17:33 UTC |
Weipert TeresaGeneral Mgr US Federal Segment
|
SaleCommon Stock | 1,444 | $74.68 | $107,837.92 |
DisclosureSEC source: 0001032220-23-000087 · primary_doc.xml · nonDerivative · entry 1 Weipert Teresa · CIK 0001856024 · General Mgr US Federal Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,493.31 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units F2 · balance_after: In addition, the reporting person holds 5350.472 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 17:25 UTC |
Mutryn DavidChief Financial Officer
|
SaleCommon Stock | 3,886 | $74.68 | $290,206.48 |
DisclosureSEC source: 0001032220-23-000086 · primary_doc.xml · nonDerivative · entry 1 Mutryn David · CIK 0001896008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,007.76 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 10355.345 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 18:21 UTC |
Baylinson Ilene R.General Mgr - Health & Human
|
SaleCommon Stock | 7,073 | $74.68 | $528,211.64 |
DisclosureSEC source: 0001032220-23-000089 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,083 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 8977.76 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 17:14 UTC |
Caswell BruceCEO & President
|
SaleCommon Stock | 21,049 | $74.68 | $1,571,939.32 |
DisclosureSEC source: 0001032220-23-000088 · primary_doc.xml · nonDerivative · entry 1 Caswell Bruce · CIK 0001311296 · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,010 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 19732.446 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
| September 28, 2023 Filed Oct 2, 2023 17:18 UTC |
Link Michelle F.Chief of Human Resources
|
SaleCommon Stock | 2,384 | $74.68 | $178,037.12 |
DisclosureSEC source: 0001032220-23-000085 · primary_doc.xml · nonDerivative · entry 1 Link Michelle F. · CIK 0001808982 · Chief of Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,979.77 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 5066.458 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.